Table 3.
Univariable and multivariable analyses for each clinical feature.
| Clinical feature | Number | Univariate analysis HR 95%CL of HR P-value |
Multivariate analysis HR 95%CL of HR P-value |
|---|---|---|---|
| RiskScore (High‐risk/Low‐risk) |
274/256 | 1.070 1.052-1.089 0.00 | 1.054 1.029-1.079 0.00 |
| Age (≥ 66/< 66) | 262/266 | 1.667 1.080-2.571 0.02 | 1.309 0.775-2.209 0.31 |
| Stage (I-II/III–IV) | 381/149 | 2.013 1.662-2.438 0.00 | 1.404 1.055-1.869 0.02 |
| Grade (G1-2/G3–4) | 216/314 | 2.593 1.804-3.725 0.00 | 1.684 1.092-2.596 0.02 |
| Residual tumor (yes/no) | 75/365 | 2.888 1.784-4.674 0.00 | 0.788 0.415-1.496 0.47 |
| New tumor event (yes/no) |
60/470 | 4.451 2.863-6.921 0.00 | 2.010 1.120-3.606 0.02 |
| Neoplasm cancer status (with tumor/tumor free) |
76/418 | 8.860 5.704-13.761 0.00 | 3.079 1.514-6.262 0.00 |
| Percent tumor invasion (yes/no) | 43/414 | 1.008 1.001-1.015 0.02 | 1.006 0.998-1.015 0.12 |